Salute e Benessere
Cardiovascular Drugs Market to 2030: APAC Leads Growth and Telehealth Helps Online Pharmacies Expand, Says Mordor Intelligence
The Asia-Pacific region leads the cardiovascular drug market, driven by reforms and expanding healthcare infrastructure, which also boost opportunities for local companies and increase competition for international players. Japan's faster approval process supports the adoption of advanced therapies, including newer anticoagulants and metabolic treatments.
North America continues to be a hotspot for innovation, with reimbursement systems favoring quick uptake of new therapies, though evolving pricing policies may influence how high-value drugs are launched.
New drug classes are reshaping treatment pathways. NOACs are rapidly replacing warfarin, while SGLT2 inhibitors and GLP-1 agonists extend beyond diabetes to heart-failure care and risk reduction, opening new market segments.
Pricing reforms and expanded reimbursement in markets like China , India , and Brazil are boosting access to advanced cardiovascular drugs. Local manufacturing incentives and broader coverage are unlocking significant patient pools and fueling sustained market growth.
Cardiovascular disease is surging among older populations, with heart-failure prevalence climbing sharply. This ageing trend, seen globally, is driving demand for personalized therapies and combination treatments.
The cardiovascular drugs market is segmented by drug class, disease indication, route of administration, distribution channel, and geography. Each segment plays a critical role in shaping the market's dynamics.
The cardiovascular drugs market is moderately competitive, with companies focusing on expanding their product portfolios, strategic alliances, and regulatory approvals. Market participants are also emphasizing biologics, biosimilars, and digital health integration to enhance patient monitoring and treatment outcomes.
These firms continue to invest in clinical research and global partnerships to strengthen their foothold in the evolving cardiovascular therapeutics space.
Anti Inflammatory Drugs Market: The Anti-inflammatory drugs market report Segments the Industry Into by Application (Arthritis, Chronic Obstructive Pulmonary Disease ), Drug Class (Anti-Inflammatory Biologics, Nsaids), Route of Administration (Oral, Parenteral), Sales Channel (Prescription, Over the Counter), and Geography ( North America , Europe , Asia-Pacific ).
The anti-obesity drugs market is projected to expand from
USD 25.93 billion in 2025 to
USD 100.97 billion by 2030, representing a CAGR of 31.24%. This growth is driven by the strong efficacy of GLP-1 receptor agonists, rising awareness of obesity as a chronic condition, and broader reimbursement coverage in developed markets.
https://www.mordorintelligence.com/industry-reports/anti-obesity-drugs-market
Omega-3 Prescription Drugs Market: The omega-3 prescription drugs Market report is Segmented by Product Type (EPA-Only, EPA + DHA Ethyl Esters, Indication (Severe Hypertriglyceridemia, Cardiovascular), Dosage Form (Soft-Gel Capsules 1g, Soft-Gel Capsules 0. 5g, Distribution Channel (Retail & Specialty Pharmacies), and Geography ( North America , Europe ).
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
media@mordorintelligence.com
https://www.mordorintelligence.com/contact-us
Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/cardiovascular-drugs-market-to-2030-apac-leads-growth-and-telehealth-helps-online-pharmacies-expand-says-mordor-intelligence-302579639.html